搜索临床试验以:SENTI-202
总计1158个结果
-
Senti Tech LtdLiverpool University Hospitals NHS Foundation Trust未知
-
Senti Biosciences招聘中反洗钱/材料数据表 | CD33 表达血液恶性肿瘤 | FLT3 表达血液恶性肿瘤美国, 澳大利亚
-
Immune-Onc TherapeuticsCalifornia Institute for Regenerative Medicine (CIRM)招聘中
-
Shanghai Zerun Biotechnology Co.,LtdWalvax Biotechnology Co., Ltd.主动,不招人
-
Devalingam MahalingamGenSpera, Inc.不再可用
-
ImmuneOncia Therapeutics Inc.尚未招聘TMB-H | 组织学或细胞学证明的转移性或局部晚期实体瘤
-
GenSpera, Inc.Food and Drug Administration (FDA)完全的
-
Oui Therapeutics, Inc.National Institute of Mental Health (NIMH)邀请报名
-
Bial - Portela C S.A.完全的
-
Shanghai Zerun Biotechnology Co.,LtdWalvax Biotechnology Co., Ltd.主动,不招人
-
Northwestern UniversityBrain & Behavior Research Foundation; Neurocentria, Inc.完全的
-
Mario Negri Institute for Pharmacological ResearchMorphoSys AG主动,不招人
-
Inversago Pharma Inc.Worldwide Clinical Trials主动,不招人
-
Memorial Sloan Kettering Cancer CenterBristol-Myers Squibb; University of Pittsburgh完全的